| Drug Name: | Salbutamol (18559-94-9) |
|---|---|
| PubChem ID: | 2083 |
| SMILES: | CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O |
| InchiKey: | NDAUXUAQIAJITI-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Reproductive Control Agents, Respiratory System Agents, Tocolytic Agents |
| Molecular Weight (dalton) | : | 239.315 |
| LogP | : | 1.306 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 72.72 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Myelosuppression | Beta-2 adrenergic receptor (P07550) | Myelosuppression [ ADR Type 1 ] | The pharmacogenetics of beta2-adrenergic receptors: relevance to asthma |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category